ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2795 • 2014 ACR/ARHP Annual Meeting

    Blockade of IL-6R Signaling by Sarilumab Suppressed Circulating Markers of Bone Resorption and Synovial Damage in Rheumatoid Arthritis Patients from a Phase 3, Randomized, Double-Blind, Placebo-Controlled, International Study

    Anita Boyapati1, Jérôme Msihid2, Emmanuelle Cousin3, Ling Cai4, Janet van Adelsberg1, Jennifer D Hamilton1, Neil Graham5, Tanya Momtahen6 and Stefano Fiore7, 1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, 2Sanofi R&D, France, Chilly-Mazarin, NJ, France, 3Sanofi R&D, France, Chilly-Mazarin, France, 4Sanofi R&D, China, Beijing, China, 5Program Direction, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, 6Sanofi, Bridgewater, NJ, 7Distinct Project Unit, Sanofi, Bridgewater, NJ

    Background/Purpose Rheumatoid arthritis (RA) patients develop bone and joint damage due to chronic inflammation mediated by critical cytokines, eg, IL-6. Pre-clinical studies have implicated IL-6…
  • Abstract Number: 2796 • 2014 ACR/ARHP Annual Meeting

    A Novel Mouse Model of Osteochondromagenesis By Deleting NFATc1 in Mesenchymal Progenitors and Postnatal Chondrocytes

    Xian-Peng Ge1, Susan Y. Ritter2, Julia F. Charles3, Kelly Tsang2 and Antonios O. Aliprantis2, 1Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 3Rheumatology, Allergy and Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Osteochondromas are the most common benign bone tumor and are characterized by cartilage-capped bony projections from the external surface of bone. These lesions may…
  • Abstract Number: 2797 • 2014 ACR/ARHP Annual Meeting

    Anti-Citrullinated Proteins Antibodies Promotes Osteoclastogenesis and Bone Destruction in Rheumatoid Arthritis

    Akilan Krishnamurthy1, Vijay Joshua1, Heidi Wähämaa1, Catia Cerqueira1, Lars Klareskog2, Vivianne Malmström3, Jimmy Ytterberg1 and Anca I Catrina1, 1Medicine, Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 2Department of Medicine, Rheumatology Unit, Karolinska Institute, Stockholm, Sweden, 3Medicine, Rheumatology Unit, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose Presence of anti-citrullinated protein antibodies (ACPA) is a major risk factor for bone erosion in rheumatoid arthritis (RA) and antibodies against modified citrullinated vimentin…
  • Abstract Number: 2798 • 2014 ACR/ARHP Annual Meeting

    C5orf30 a Novel Regulator of Inflammation and Tissue Damage in Rheumatoid Arthritis

    Munitta Muthana1, Sarah Hawtree1, Holly Davies2, Hannah Roberts1, Sachin Khetan1, Mohammed Akil3, Fiona Wright1, Barbara Ciani4, Ursula Fearon5, DJ Veale6 and Anthony G. Wilson7, 1Infection and Immunity, University of Sheffield, Sheffield, United Kingdom, 2University of Sheffield, Sheffield, United Kingdom, 3Rheumatology Department, Sheffield South Yorkshire, United Kingdom, 4Chemistry, University of Sheffield, Sheffield, United Kingdom, 5Dublin Academic Medical Centre, Translational Rheumatology Research Group, Dublin, Ireland, 6Consultant Rheumatologist, St. Vincent’s University Hospital, Dublin, Ireland, 7Conway Institute of Biomolecular & Biomedical Research, University College Dublin, Dublin, Ireland

    Background/Purpose A recent genome wide association study identified the variant rs26232 in the first intron of the uncharacterized gene, C5orf30, as a rheumatoid arthritis (RA)…
  • Abstract Number: 2799 • 2014 ACR/ARHP Annual Meeting

    The Differential Impact of Obesity on the Pathogenesis of RA or Preclinical Models Is Contingent on the Disease Status  

    Zhenlong Chen1, Seung-jae Kim1, Abdul Essani2, Michael V. Volin3, Suncica Volkov1, William Swedler4, Shiva Arami2, Giamila Fantuzzi2, Nadera J. Sweiss5 and Shiva Shahrara1, 1Medicine/Rheumatology, University of Illinois at Chicago, Chicago, IL, 2University of Illinois at Chicago, Chicago, IL, 3Department of Microbiology and Immunology, Chicago College of Osteopathic Medicine Midwestern University, Downers Grove, IL, 4Section of Rheumatology, University of Illinois at Chicago, Chicago, IL, 5internal medicine section of rheumatology, University of Illinois at Chicago, Chicago, IL

    Background/Purpose: Studies were performed to determine the significance of obesity in the pathogenesis of rheumatoid arthritis (RA) and experimental arthritis models. Methods: Chronic and acute…
  • Abstract Number: 2800 • 2014 ACR/ARHP Annual Meeting

    Tofacitinib Regulates Synovial Angiogenesis in Psoriatic Arthritis through Induction of Negative Feedback Inhibitors

    Wei Gao, Jennifer McCormick, Carl Orr, Mary Connolly, Ursula Fearon and Douglas J. Veale, Dublin Academic Medical Centre, Translational Rheumatology Research Group, Dublin, Ireland

    Background/Purpose: Psoriatic Arthritis (PsA) is a common, chronic immune-mediated inflammatory disease, characterised by synovitis, progressive destruction of articular cartilage/bone, and is associated with psoriasis. Janus…
  • Abstract Number: 2801 • 2014 ACR/ARHP Annual Meeting

    IL-38: A New Factor in Rheumatoid Arthritis   

    Shinjiro Kaieda1, Katsuya Kanezaki2, Naomi Yoshida3, Yukiko Kunitake3, Hiroaki Ida3 and Tomoaki Hoshino3, 167 Asahi-machi, Kurume, Fukuoka, Kurume University School of Medicine, Kurume, Japan, 2Nagata orthopedic hospital, Omuta, Japan, 3Kurume University School of Medicine, Kurume, Japan

    Background/Purpose: IL-38 (IL-1F10) was originally described as an IL-1 family cytokine, and named IL-1HY2. The IL-38 gene is located in the IL-1 family cluster on…
  • Abstract Number: 2802 • 2014 ACR/ARHP Annual Meeting

    Non-Canonical NF-Kappab Signaling Promotes Angiogenesis in a Novel 3D Spheroid Model of Rheumatoid Arthritis Synovial Inflammation

    Chrissta X. Maracle1, Boy Helder2, Ae-Ri Noort1, Corine van der Horst3 and Sander W. Tas1, 1Department of Clinical Immunology & Rheumatology and Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 2Department of Clinical Immunology and Rheumatology and Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 3Arthrogen BV, Amsterdam, Netherlands

    Background/Purpose: Angiogenesis is regarded as a switch from acute to chronic inflammation and thus plays a crucial role in rheumatoid arthritis disease progression. This process…
  • Abstract Number: 2803 • 2014 ACR/ARHP Annual Meeting

    Methotrexate Impacts the Effects of Tofacitinib, but Not Tocilizumab, on Clinically Relevant Biomarkers in Human Primary Cell–Based BioMAP® Disease Models: Can We Utilize in Vitro Models to Predict Clinical Outcomes?

    Alison O'Mahony1, Ellen L. Berg1, Xitong Li1, Markus R. John2, Kandeepan Ganeshalingam2 and Ernest H. Choy3, 1BioSeek, South San Francisco, CA, 2F. Hoffmann-La Roche, Basel, Switzerland, 3Cardiff University, Cardiff, United Kingdom

    Background/Purpose: A number of trials have shown that adding MTX benefits some, but not all, biologics and small molecules to treat RA. Specifically, though treatment…
  • Abstract Number: 2804 • 2014 ACR/ARHP Annual Meeting

    Rituximab in IgG4-Related Disease: A Large Single-Center Experience

    Zachary Wallace1, Mollie Carruthers1 and John H. Stone2, 1Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, 2Rheumatology, Massachusetts General Hospital, Boston, MA

    Background/Purpose IgG4-related disease (IgG4-RD) is an immune-mediated multiorgan, fibroinflammatory disease often associated with an elevated serum IgG4 concentration.  The diagnosis hinges on characteristic histopathologic features. …
  • Abstract Number: 2805 • 2014 ACR/ARHP Annual Meeting

    IgG4-Related Disease: Baseline Features in 100 Patients with Biopsy-Proven Disease

    Zachary Wallace1, Vikram Deshpande2, Hamid Mattoo3, Vinay Mahajan4, Mollie Carruthers1, Maria Kulikova5, Shiv Pillai6 and John H. Stone7, 1Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, 2Pathology, Massachusetts General Hospital, Boston, MA, 3Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 4Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 5Massachusetts General Hospital, Boston, MA, 6Oncology, Massachusetts General Hospital, Boston, MA, 7Rheumatology, Massachusetts General Hospital, Boston, MA

    Background/Purpose IgG4-related disease (IgG4-RD) has emerged as an immune-mediated disease that links multiple fibro-inflammatory conditions through common pathology and pathophysiologic mechanisms.  Most of the literature…
  • Abstract Number: 2806 • 2014 ACR/ARHP Annual Meeting

    Characteristic Phenotype of Peripheral Blood Lymphocytes in Patients with IgG4-Related Disease, Comparing to Primary Sjögren Syndrome and Healthy Controls

    Shintaro Hirata, Shingo Nakayamada, Satoshi Kubo, Maiko Yoshikawa, Naoki Yunoue, Kazuhisa Nakano, Kunihiro Yamaoka, Kazuyoshi Saito and Yoshiya Tanaka, The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan

    Background/Purpose : IgG4-related disease (IgG4-RD) is a systemic disease that is characterized by the infiltration of IgG4-positive plasma cells and T cells into various organs.…
  • Abstract Number: 2807 • 2014 ACR/ARHP Annual Meeting

    Comparison of Outcomes in Septic Arthritis Caused By MRSA and MSSA

    Deepa Panikkath1, Sian Yik Lim2, Swetha Gadwala3, Ragesh Panikkath3 and Kenneth Nugent4, 1INTERNAL MEDICINE, Texas Tech University of Health Sciences, Lubbock, LUBBOCK, TX, 2Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, 3Internal Medicine, Texas Tech University of Health Sciences, Lubbock, TX, 43601, Texas Tech University Health Sciences Center, Lubbock, TX

    Background/Purpose:  Staphylococcus aureus is the most common cause of adult septic arthritis and the incidence of methicillin-resistant Staphylococcus aureus (MRSA) infections continues to rise. There…
  • Abstract Number: 2809 • 2014 ACR/ARHP Annual Meeting

    Human Papilloma Virus and Chlamydia Trachomatis Infections in Rheumatoid Arthitis Under Anti-TNF Therapy

    Mariana G Waisberg1, Ana C.M. Ribeiro2, Wellington M. Candido1, Poliana B. Medeiros1, Cezar N. Matsuzaki3, Mariana C. Beldi1, Maricy Tacla1, Helio H. Caiaffa-Filho4, Eloisa Bonfá1 and Clovis A Silva5, 1Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, 2Rheumatology Division, University of Sao Paulo, Sao Paulo, Brazil, 3Gynecology Department, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, 4Central Laboratory Division, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, 5Pediatric Rheumatology Unit, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

    Background/Purpose: Cervical human papillomavirus (HPV) infection has been observed in 28% of rheumatoid arthritis (RA) patients in a cross-sectional study with no available data regarding…
  • Abstract Number: 2810 • 2014 ACR/ARHP Annual Meeting

    Reduced Mortality Risk in Rheumatoid Arthritis: Findings from Two UK Inception Cohorts

    Sam Norton1, Elena Nikiphorou2, Lewis Carpenter3, David Walsh4,5, Patrick Kiely6, Josh Dixey7 and Adam Young2,8, 1Institute of Psychiatry, King's College London, London, United Kingdom, 2School of Life & Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom, 3Centre for Lifespan & Chronic Illness Research, University of Hertfordshire, Hatfield, United Kingdom, 4Arthritis Research UK Pain Centre, University of Nottingham, Nottingham, United Kingdom, 5Rheumatology, Sherwood Forest Hospitals NHS Foundation Trust, Sutton-in-Ashfield, United Kingdom, 6Rheumatology Dept, St. Georges Healthcare NHS Trust, London, United Kingdom, 7Rheumatology, New Cross Hospital, Wolverhampton, United Kingdom, 8Rheumatology, ERAS, St Albans City Hospital, St Albans, United Kingdom

    Background/Purpose Rheumatoid arthritis (RA) is associated with a 20 to 30% increased risk of mortality from all-causes compared to the general population. The aim of…
  • « Previous Page
  • 1
  • …
  • 2045
  • 2046
  • 2047
  • 2048
  • 2049
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology